{"id":2579,"date":"2019-10-06T21:21:19","date_gmt":"2019-10-06T19:21:19","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2579"},"modified":"2025-01-28T15:39:32","modified_gmt":"2025-01-28T14:39:32","slug":"nutricio-metabolisme-i-terapia-genica","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-medicina-translacional\/programa-de-diabetis-i-metabolisme\/nutricio-metabolisme-i-terapia-genica\/","title":{"rendered":"Nutrici\u00f3, Metabolisme i Ter\u00e0pia G\u00e8nica"},"content":{"rendered":"\n
Garcia-Roves Gonzalez, Pablo Miguel (Investigador principal (IP))<\/p>\n
Ref.: PI15\/00701<\/p>\n
Entitat finan\u00e7adora:<\/p>\n
2016-01-01 – 2018-12-31<\/p>\n
Bartrons Bach, Ramon (Investigador principal (IP))<\/p>\n
Ref.: EEBB-2011-44136<\/p>\n
Entitat finan\u00e7adora:<\/p>\n
2011-01-01 – 2011-12-31<\/p>\n
Bartrons Bach, Ramon (Investigador principal (IP))<\/p>\n
Ref.: BUF2009-07380<\/p>\n
Entitat finan\u00e7adora:<\/p>\n
2010-01-01 – 2012-12-31<\/p>\n
Bartrons Bach, Ramon (Investigador principal (IP))<\/p>\n
Ref.: FPI-BES-2007-16437<\/p>\n
Entitat finan\u00e7adora:<\/p>\n
2009-07-02 – 2011-07-01<\/p>\n
Javierre Garces, Casimiro (Investigador principal (IP))<\/p>\n
Ref.: 07PRV009<\/p>\n
Entitat finan\u00e7adora:<\/p>\n
2007-05-04 – 2010-05-03<\/p>\n
Bartrons Bach, Ramon (Investigador principal (IP))<\/p>\n
Ref.: BFU2006-02412<\/p>\n
Entitat finan\u00e7adora:<\/p>\n
2007-01-01 – 2009-09-30<\/p>\n
Bartrons Bach, Ramon (Investigador principal (IP))<\/p>\n
Ref.: 94VAR026<\/p>\n
Bartrons Bach, Ramon (Investigador principal (IP))<\/p>\n
Ref.: MTV3<\/p>\n
Entitat finan\u00e7adora:<\/p>\n
2006-01-01 – 2009-12-31<\/p>\n
Perales Losa, Jose Carlos (Investigador principal (IP))<\/p>\n
Ref.: 31633<\/p>\n
2006-01-01 – 2009-12-31<\/p>\n
See full list<\/a><\/p>\n\t\t\t\t Nutrici\u00f3, metabolisme i ter\u00e0pia g\u00e8nica Resum El grup se centra en estudiar les implicacions metab\u00f2liques de malalties cr\u00f2niques com l’obesitat, la diabetis i el c\u00e0ncer. Mitjan\u00e7ant la ter\u00e0pia g\u00e8nica, el grup t\u00e9 com a objectiu modificar el genoma o la regulaci\u00f3 gen\u00f2mica d’un pacient mitjan\u00e7ant diverses estrat\u00e8gies, amb la finalitat de reempla\u00e7ar una escassetat causada […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":540,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-2579","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2025-03-02 04:38:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=2579"}],"version-history":[{"count":10,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2579\/revisions"}],"predecessor-version":[{"id":27097,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2579\/revisions\/27097"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/540"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=2579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n\t\tGarcia-Roves Gonzalez, Pablo\n\t<\/h4>\n
\n\t\t\n\t\tpgarciaroves@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t
\n
\n\t\tGarcia-Roves Gonzalez, Pablo\n\t<\/h4>\n
\n\t\t\n\t\tpgarciaroves@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t
\n
\n\t\tPerales Losa, Jose Carlos\n\t<\/h4>\n
\n\t\t\n\t\tjperales@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t
\n
\n\t\tMendez Lucas, Andres\n\t<\/h4>\n\t\t\t\t
\n
\n\t\tManzano Cuesta, Anna\n\t<\/h4>\n
\n\t\t\n\t\tamanzano@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n
\n\t\t\n\t\t@m_roves\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@Aml_Metab\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es principals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n\t\tNoticias relacionadas\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tGeneren un model de ratol\u00ed que permetr\u00e0 estudiar la progressi\u00f3 d’un tipus de la leuc\u00e8mia i buscar tractaments m\u00e9s efica\u00e7os<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t15\/12\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn estudi troba que l’agonista del receptor GLP-1 millora la funci\u00f3 mitocondrial en ratolins amb obesitat<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t27\/04\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl teixit adip\u00f3s blanc \u00e9s el m\u00e9s vulnerable davant dels canvis metab\u00f2lics causats per l’obesitat<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/07\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tNoves descobertes sobre la funci\u00f3 supressora de tumors de les prote\u00efnes HERC<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/02\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl consorci europeu IT-LIVER amplia el coneixement del paper del TGF-beta en c\u00e0ncer de fetge<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/02\/2018\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescobreixen un mecanisme que converteix les c\u00e8l\u2022lules tumorals en addictes al sucre<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/04\/2014\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLlicenciada una patent a Janus Developments pel tractament de malalties inflamat\u00f2ries<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t28\/01\/2013\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"